Clinical Trials
9
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)โข Click on a phase to view related trials
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 38
- Registration Number
- NCT03081481
- Locations
- ๐บ๐ธ
Vantage Health, Ocala, Florida, United States
๐บ๐ธChesapeake Urology Associates, Baltimore, Maryland, United States
๐บ๐ธNew York Urology Associates, New York, New York, United States
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 18
- Registration Number
- NCT02499848
- Locations
- ๐ฌ๐ง
UCLH, London, United Kingdom
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
- First Posted Date
- 2013-10-21
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 479
- Registration Number
- NCT01966614
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 40
- Registration Number
- NCT01454349
- Locations
- ๐บ๐ธ
South Orange County Medical Research Center, Laguna Hills, California, United States
๐บ๐ธAtlantic Urology Medical Group, Long Beach, California, United States
๐บ๐ธCalifornia Professional Research, Newport Beach, California, United States
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2018-11-21
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 92
- Registration Number
- NCT00889707
- Locations
- ๐จ๐ฆ
Andreou Research, Surrey, British Columbia, Canada
๐จ๐ฆCanMed Clinical Research Inc., Victoria, British Columbia, Canada
๐จ๐ฆDr. Steinhoff Clinical Research, Victoria, British Columbia, Canada
- Prev
- 1
- 2
- Next